Primary Progressive MS (PPMS): What It Means & How Home Health Helps
Primary progressive multiple sclerosis (PPMS) affects 10 to 15 percent of people with MS. Unlike relapsing-remitting MS, PPMS is characterized by steady worsening of neurological function from the very first symptom – without distinct relapses and without remissions. PPMS typically presents about a decade later than RRMS, with an average age of onset around 40, and affects men and women in roughly equal numbers (some studies show slight male predominance).
Typical PPMS Patient Profile
- Average age of onset around 40 (vs. 20s-30s for RRMS)
- Roughly equal in men and women (some male predominance)
- Spinal cord more affected than the brain - mobility decline dominates
- Median time from onset to needing a walking aid: approximately 7 years untreated, longer with modern treatment
- FDA-approved DMT for PPMS: ocrelizumab (Ocrevus)
- Cognitive symptoms also appear, with fatigue and bladder dysfunction nearly universal
Our Promise
If you choose us, here’s what we promise: clinical care delivered by people who know MS. A care plan built around your specific symptoms, your specific home, and your specific family. Honest answers about what Medicare covers and what it doesn’t. And the kind of communication that means you never feel like you’re chasing us for an update.
How Skilled Home Health Helps PPMS Patients : Primary progressive ms
Earlier Home Health Introduction
PPMS often requires home health earlier than RRMS because disability arrives without the remission periods that allow recovery. Many PPMS patients benefit from skilled care within the first few years of diagnosis.
Mobility-Focused PT
Because PPMS affects the spinal cord more than the brain, mobility decline is the dominant feature for most patients. PT works on gait, balance, transfers, and assistive device fitting. Maintenance PT under Jimmo continues as long as needed.
Ocrevus Coordination
Ocrelizumab (Ocrevus) is the FDA-approved DMT for PPMS, administered as IV infusion every 6 months at infusion centers. Skilled nursing coordinates pre-infusion screening, post-infusion monitoring, and management of infusion reactions and infection risk between doses.
Symptom Management
Bladder dysfunction, spasticity, fatigue, and cognitive symptoms in PPMS require the same comprehensive symptom management as in other MS types – managed by the home health team in collaboration with the treating neurologist.
PPMS is the type of MS where the Jimmo Settlement most clearly matters – and where it is most often improperly applied. Because PPMS by definition does not improve, Medicare contractors and Medicare Advantage plans sometimes deny coverage on the grounds that the patient is not progressing toward goals. This is exactly the Improvement Standard violation that Jimmo prohibited.
PPMS patients and their families should be aware of this. If you ever encounter resistance to ongoing PT, OT, or skilled nursing on the grounds that improvement is not happening, that is a Jimmo issue, and it is appealable. Our medical social worker helps families navigate these situations.